$330 Million is the total value of BRIDGER MANAGEMENT, LLC's 43 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 23.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GDDY | Sell | GODADDY INCcl a | $25,825,000 | -16.7% | 364,353 | -18.3% | 7.83% | +12.0% |
| ALC | Sell | ALCON AG | $15,702,000 | -28.2% | 269,892 | -13.8% | 4.76% | -3.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $11,516,000 | -44.1% | 39,772 | -45.6% | 3.49% | -24.7% |
| HUM | Sell | HUMANA INC | $10,189,000 | -37.8% | 21,000 | -40.0% | 3.09% | -16.3% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $9,493,000 | -13.9% | 916,314 | -4.2% | 2.88% | +15.9% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $8,577,000 | -65.5% | 156,400 | -58.5% | 2.60% | -53.6% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $8,511,000 | -50.6% | 100,400 | -51.7% | 2.58% | -33.5% |
| Sell | AIRSCULPT TECHNOLOGIES INC | $8,347,000 | -13.9% | 1,298,141 | -20.6% | 2.53% | +15.9% | |
| VRSN | Sell | VERISIGN INC | $8,156,000 | -48.0% | 46,953 | -49.9% | 2.47% | -30.0% |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $5,265,000 | -62.6% | 446,607 | -59.2% | 1.60% | -49.7% |
| Sell | RXSIGHT INC | $2,661,000 | -43.0% | 221,732 | -33.1% | 0.81% | -23.3% | |
| CNC | Sell | CENTENE CORP DEL | $2,199,000 | -91.8% | 28,263 | -91.1% | 0.67% | -89.0% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $1,633,000 | -30.7% | 45,235 | -41.6% | 0.50% | -6.8% |
| LIVN | Sell | LIVANOVA PLC | $1,360,000 | -61.0% | 26,790 | -52.1% | 0.41% | -47.5% |
| Sell | DERMTECH INC | $826,000 | -57.5% | 208,600 | -40.5% | 0.25% | -42.7% | |
| MSOS | Sell | ADVISORSHARES TRpure us cannabis | $499,000 | -77.5% | 55,958 | -73.9% | 0.15% | -69.8% |
| TECH | Exit | BIO-TECHNE CORP | $0 | – | -1,444 | -100.0% | -0.11% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -66,300 | -100.0% | -0.17% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -278,000 | -100.0% | -0.28% | – |
| PODD | Exit | INSULET CORP | $0 | – | -41,000 | -100.0% | -2.01% | – |
| CLVT | Exit | CLARIVATE PLC | $0 | – | -1,641,319 | -100.0% | -5.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.